id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0345-0002,FDA,FDA-2005-N-0345,"Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures",Notice,Notice of Final Rule,2008-10-09T04:00:00Z,2008,10,,,2015-11-04T15:36:44Z,E8-24050,0,0,09000064807410a4